Number of the records: 1
Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients
Title Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients Author Hříbková Hana Co-authors Svoboda Ondřej Bartecku Elis Zelinková Jana Hořínková Jana Lacinová Ľubica 1959- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS ORCID Piskáček Martin Lipový Břetislav Provazník I. Glover Joel C. Kašpárek Tomáš Sun Yuh-Man Source document Frontiers in Cellular Neuroscience. Vol. 16, (2022), art. no. 830757 Language eng - English Country CH - Switzerland URL URL link Document kind rozpis článkov z periodík (rbx) Citations QUBAD, M. - BITTNER, R.A. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. In THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY. ISSN 2045-1253, 2023, vol. 13. Dostupné na: https://doi.org/10.1177/20451253231158152. SUN, Y.M. - CHEN, J. Editorial: New insights into schizophrenia-related neural and behavioral phenotypes. In FRONTIERS IN CELLULAR NEUROSCIENCE. MAY 10 2023, vol. 17. Dostupné na: https://doi.org/10.3389/fncel.2023.1202230. SPEERS, L.J. - CHIN, P. - BILKEY, D.K. No evidence that acute clozapine administration alters CA1 phase precession in rats. In BRAIN RESEARCH. ISSN 0006-8993, SEP 1 2023, vol. 1814. Dostupné na: https://doi.org/10.1016/j.brainres.2023.148446. BITTNER, R.A. - REIF, A. - QUBAD, M. The ever-growing case for clozapine in the treatment of schizophrenia: an obligation for psychiatrists and psychiatry. In CURRENT OPINION IN PSYCHIATRY. ISSN 0951-7367, JUL 2023, vol. 36, no. 4, p. 327-336. Dostupné na: https://doi.org/10.1097/YCO.0000000000000871. NGAMRATANAPAIBOON, S. - SRIKORNVIT, N. - HONGTHAWONSIRI, P. - PORNCHOKCHAI, K. - WONGPITOONMANACHAI, S. - PHOLKLA, P. - MO, J. - YAMBANGYANG, P. - AYUTTHAYA, W.D.N. Exploring the mechanisms of clozapine-induced blood-brain barrier dysfunction using untargeted metabolomics and cellular metabolism analysis. In ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY. ISSN 1382-6689, SEP 2023, vol. 102. Dostupné na: https://doi.org/10.1016/j.etap.2023.104219. TIBREWAL, P. - NAIR, P.C. - GREGORY, K.J. - LANGMEAD, C.J. - CHAN, S.K.W. - BASTIAMPILLAI, T. Does clozapine treat antipsychotic-induced behavioural supersensitivity through glutamate modulation within the striatum?. In MOLECULAR PSYCHIATRY. ISSN 1359-4184, MAY 2023, vol. 28, no. 5, p. 1839-1842. Dostupné na: https://doi.org/10.1038/s41380-023-02026-x. FAN, L.J. - LIANG, L.B. - WANG, Y.J. - MA, X.Q. - YUAN, L. - OUYANG, L.J. - HE, Y. - LI, Z.C. - LI, C.W. - CHEN, X.G. - PALANIYAPPAN, L. Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex. In NEUROPSYCHOPHARMACOLOGY. ISSN 0893-133X, APR 2024, vol. 49, no. 5, p. 845-853. Dostupné na: https://doi.org/10.1038/s41386-023-01741-x. SAPIENZA, J. - AGOSTONI, G. - DALL'ACQUA, S. - SUT, S. - NASINI, S. - MARTINI, F. - MARCHESI, A. - BECHI, M. - BUONOCORE, M. - COCCHI, F. - CAVALLARO, R. - SPANGARO, M. - COMAI, S. - BOSIA, M. The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy. In SCHIZOPHRENIA RESEARCH. ISSN 0920-9964, FEB 2024, vol. 264, p. 71-80. Dostupné na: https://doi.org/10.1016/j.schres.2023.12.005. Category ADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 Registered in WOS Registered in SCOPUS DOI 10.3389/fncel.2022.830757 
article
File name Access Size Downloaded Type License Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients.pdf available 3.7 MB 1 Publisher's version 
CC BY 4.0rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore N rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 6.147 Q1 1.661 Q1
Number of the records: 1